ArticleThe Journal of comparative neurology2025
Ultrastructural Synaptic Differences in the Central Inferior Colliculus in the 3xTG Mouse Across Three Disease Stages.
Article in The Journal of comparative neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Age-related differences in asymmetric synapses across the central inferior colliculus in the Fischer Brown Norway rat.Aging brain · 2026Article
- Ultrastructural Synaptic Differences in the Central Inferior Colliculus in the 3xTG Mouse Across Three Disease Stages.The Journal of comparative neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Numerous studies support a mechanistic link between hearing loss and increased risks of cognitive decline and dementia. Hearing loss is widely viewed as a modifiable risk factor for Alzheimer's disease (AD). During normal aging the inferior colliculus (IC), a large auditory midbrain nucleus, undergoes numerous changes to neurotransmission, and these changes contribute to the development of central gain and presbycusis. Recent reports also implicate the IC as a nucleus that undergoes processing changes during AD. We used transmission electron microscopy (EM) to examine the synaptic ultrastructure of the central IC (ICc) in 3xTG mice during presymptomatic, emerging, and established disease stages. Synapses were identified by a collection of presynaptic vesicles, a clear synaptic cleft, and a postsynaptic density. Symmetric synapses had pre and postsynaptic membranes of similar thickness, whereas asymmetric synapses had postsynaptic densities were conspicuously thicker than the presynaptic densities. We also quantified the presynaptic profile areas, active zone lengths, and presynaptic mitochondria. The data demonstrate a significant loss of symmetric and asymmetric synapses in the emerging disease stage. In particular, the density of symmetric synapses in the ICc was reduced by ∼50%. As inhibitory neurotransmitters gamma-aminobutyric acid (GABA), glycine, and neuropeptide Y are released from neurons that form symmetric synapses in the IC, the robust loss of these synapses may contribute to central gain and presbycusis during AD. Furthermore, as these synapses were lost well before the established disease stages, perhaps alterations in ICc represent an early biomarker for Alzheimer's progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.